Trial Profile
Comparison of the efficacy of capecitabine (Xeloda) with continuous administration of 5-fluorouracil in the preoperative concomitant treatment with radiotherapy in rectal carcinoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 29 Nov 2016 New trial record